# To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris

> **NCT04960930** · PHASE3 · COMPLETED · sponsor: **Cutia Therapeutics (Shanghai) Co., Ltd** · enrollment: 372 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** FMX101

## Key facts

- **NCT ID:** NCT04960930
- **Lead sponsor:** Cutia Therapeutics (Shanghai) Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-17
- **Primary completion:** 2022-09-27
- **Final completion:** 2022-10-14
- **Target enrollment:** 372 (ACTUAL)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04960930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04960930, "To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04960930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*